- Home
- FEBO vs INM Comparison
FEBO vs INM Comparison
Compare FEBO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.37
Company Overview
Basic Information| Metric | FEBO | INM |
|---|---|---|
| Founded | 1993 | 1981 |
| Country | Hong Kong | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9M | 7.7M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FEBO | INM |
|---|---|---|
| Price | $0.72 | $1.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.1K | ★ 69.5K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.61 | $0.58 |
| 52 Week High | $1.46 | $2.50 |
Technical Indicators
Market Signals| Indicator | FEBO | INM |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 42.43 |
| Support Level | $0.66 | $1.35 |
| Resistance Level | $0.76 | $1.40 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 42.86 | 20.00 |
Price Performance
Historical Comparison FEBO
INM
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.